ANDREA BLATTLER: Open Payments
NPI 1912013707 · SPRINGFIELD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 23 payments from 12 companies in 2025. Trend: 2023 $113 · 2024 $471 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 3 | $51 |
| Amgen Inc. | 2 | $48 |
| Edwards Lifesciences Corporation | 2 | $44 |
| Novo Nordisk Inc | 2 | $34 |
| ABIOMED | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| PFIZER INC. | 1 | $16 |
Products named: ELIQUIS, LEQVIO, AMVUTTRA, REPATHA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Wegovy, Kerendia, VERQUVO.
Industry payments across OR — which companies pay providers there.
